Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2610
Title: Diabetes in a child on growth hormone therapy: Answers
Authors: Prado, J.
Aldridge, M.
Huynh, T.
McTaggart, S. J.
Issue Date: 2018
Source: 33, (1), 2018, p. 79-80
Pages: 79-80
Journal: Pediatric Nephrology
Abstract: L6150558412017-04-03
2017-12-12
DOI: 10.1007/s00467-017-3651-2
Resources: https://www.embase.com/search/results?subaction=viewrecord&id=L615055841&from=exporthttp://dx.doi.org/10.1007/s00467-017-3651-2 |
Keywords: HNF1beta gene;hormonal therapy;human;hyperglycemia;insulin sensitivity;priority journal;renal cysts and diabetes syndrome;risk factor;gene mutation;hepatocyte nuclear factor 1beta;recombinant growth hormone;recombinant somatomedin C;somatomedin C;article;beta cell dysfunction;cell damage;child;developmental delay;diabetes mellitus;disease association;drug effect;drug safety;endocrine disease;glucosehemoglobin A1c;glucose intolerance
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

48
checked on Mar 20, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.